06:03 EDT GoodRx sees FY23 revenue ~$750M-$760M, consensus $762.25M
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GDRX:
- Notable companies reporting before tomorrow’s open
- Adobe upgraded, Salesforce downgraded: Wall Street’s top analyst calls
- GoodRx upgraded to Outperform at TD Cowen after ‘game changer’ PBM partnerships
- GoodRx upgraded to Outperform from Market Perform at TD Cowen
- GoodRx price target raised to $8 from $6 at Morgan Stanley